EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase
about
Eph receptors as therapeutic targets in glioblastomaEphs and Ephrins in malignant gliomasEpithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastomaLipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicityLGR5 is required for the maintenance of spheroid-derived colon cancer stem cells.The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype.Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like CellsAligned Nanotopography Promotes a Migratory State in Glioblastoma Multiforme Tumor Cells.Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.Simultaneous targeting of Eph receptors in glioblastomaCombined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma.FAK and Nanog cross talk with p53 in cancer stem cells.Therapeutic targeting of EPH receptors and their ligands.Targeting FAK in human cancer: from finding to first clinical trials.The diverse roles and multiple forms of focal adhesion kinase in brain.Eph receptors and ephrins: therapeutic opportunities.Non-genomic androgen action regulates proliferative/migratory signaling in stromal cells.Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes.Identification of approved drugs that inhibit the binding of amyloid β oligomers to ephrin type-B receptor 2.Methylated cis-regulatory elements mediate KLF4-dependent gene transactivation and cell migrationSERPINE1: A Molecular Switch in the Proliferation-Migration Dichotomy in Wound-"Activated" KeratinocytesWild-type p53 inhibits pro-invasive properties of TGF-β3 in breast cancer, in part through regulation of EPHB2, a new TGF-β target gene.Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer.The biology and mathematical modelling of glioma invasion: a review.Krüppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells.Targeting UDP-α-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration.Increased EphB2 expression predicts cholangiocarcinoma metastasis.Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers.
P2860
Q27000196-1D743E1C-D9E0-4566-AA87-A63FA5411D59Q27015780-31318CF5-3694-4054-84F6-0E67D882B753Q33619401-5A761DBB-EC5C-4991-BDEE-242E0658C21CQ33747559-63B14D6B-2B51-4CFC-8B3E-187F734DD064Q33811425-523706F6-68B8-40A6-87D6-6CFB8C5C13A1Q34552497-6743CA6E-A556-493F-B53B-53F063D62AF5Q36544941-49E97D6C-27E3-42B6-8F48-E85A071E8C29Q36557197-EA390DCC-08DB-4BCF-8481-2605D3E73284Q36705901-6463667A-114F-4426-A006-12FE41997086Q36730368-3DF81D1C-7AD4-4B0D-BF2E-86C199D5173DQ36910540-FD1C15EF-E383-44BE-BD5C-BFA3EC7A5308Q37312725-B51DC9B5-8970-4211-8651-F57624875D18Q37644953-DDEE98D1-B66E-43BB-A4F8-EF49D8EFD329Q37727021-A7318771-7F76-465E-8F8F-57E2D93D824AQ38039165-7187E352-F0AC-409B-B777-58C362CB9C72Q38174793-7AF11BAA-654A-47C7-9DC6-4A749200E091Q38175738-53644157-AD30-4A86-A31F-D8934DE0620FQ38255120-147019BA-E24A-49A7-A702-1A2B22551212Q38257853-B6C56A3A-2D83-483B-A2D6-1AB3AC37799BQ38342128-81130524-E7CE-4283-9B6F-703A4AFEBFFEQ38790923-877FD976-C4EE-4A7E-B36D-A3FF004E848DQ39171562-862A53C9-CBCB-43AB-89B7-37FD1A95AEDCQ40988553-C0B4C35F-8CE0-4B91-BD1E-9F9A89DFCB73Q42209913-7D2C7187-412B-4251-AC9E-609DA6EA0C26Q42409255-C218372C-1D43-4DDA-B348-54197FF68890Q42466219-42046BB0-122F-47E5-9557-06E79CE1FEB5Q42797700-17971CAD-5037-459F-99A0-133B33129F00Q47124238-3DA4FE64-54AA-4350-A9C6-B9488EE963E4Q51736068-93FBF330-C54F-471A-93AD-DB60091DADC6Q52686115-5D4F987B-6DAC-4EA8-9B7D-F7ED9ECB2966Q54338851-0E84F0F5-46C6-4194-A5A9-6BD6BDC0EC3CQ55286883-4CFE0979-3E8F-4356-8BC9-59303C32C613
P2860
EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
EphB2 receptor controls prolif ...... ing with focal adhesion kinase
@ast
EphB2 receptor controls prolif ...... ing with focal adhesion kinase
@en
type
label
EphB2 receptor controls prolif ...... ing with focal adhesion kinase
@ast
EphB2 receptor controls prolif ...... ing with focal adhesion kinase
@en
prefLabel
EphB2 receptor controls prolif ...... ing with focal adhesion kinase
@ast
EphB2 receptor controls prolif ...... ing with focal adhesion kinase
@en
P2093
P2860
P356
P1433
P1476
EphB2 receptor controls prolif ...... ing with focal adhesion kinase
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.16
P407
P577
2012-02-06T00:00:00Z
P5875
P6179
1002962031